Integral Molecular Partners with Merus to Discover Novel Therapeutic Monoclonal Antibodies
PHILADELPHIA – (BUSINESS WIRE) – Integral Molecular, the industry leader in the discovery of monoclonal antibodies (MAbs) against membrane proteins, and Merus N.V. (Nasdaq:MRUS), […]